ATE428693T1 - Prostaglandinsynthese - Google Patents

Prostaglandinsynthese

Info

Publication number
ATE428693T1
ATE428693T1 AT04801246T AT04801246T ATE428693T1 AT E428693 T1 ATE428693 T1 AT E428693T1 AT 04801246 T AT04801246 T AT 04801246T AT 04801246 T AT04801246 T AT 04801246T AT E428693 T1 ATE428693 T1 AT E428693T1
Authority
AT
Austria
Prior art keywords
alkyl
group
insynthesis
prostagland
halo
Prior art date
Application number
AT04801246T
Other languages
English (en)
Inventor
Derek Wyndham Clissold
Stuart Wilbert Craig
Rajendrakumar Gadikota
Min He
Jurjus Fayez Jurayj
Shahrokh Kazerani
Erwin Rannala
Pradeep Sharma
Original Assignee
Johnson Matthey Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson Matthey Plc filed Critical Johnson Matthey Plc
Application granted granted Critical
Publication of ATE428693T1 publication Critical patent/ATE428693T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C07C405/0008Analogues having the carboxyl group in the side-chains replaced by other functional groups
    • C07C405/0016Analogues having the carboxyl group in the side-chains replaced by other functional groups containing only hydroxy, etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT04801246T 2003-12-19 2004-12-01 Prostaglandinsynthese ATE428693T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0329379.2A GB0329379D0 (en) 2003-12-19 2003-12-19 Prostaglandin synthesis
PCT/GB2004/005028 WO2005058812A2 (en) 2003-12-19 2004-12-01 Prostaglandin synthesis

Publications (1)

Publication Number Publication Date
ATE428693T1 true ATE428693T1 (de) 2009-05-15

Family

ID=30471335

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04801246T ATE428693T1 (de) 2003-12-19 2004-12-01 Prostaglandinsynthese

Country Status (14)

Country Link
EP (1) EP1694641B1 (de)
JP (3) JP4764828B2 (de)
KR (1) KR20060118555A (de)
CN (2) CN101486699B (de)
AT (1) ATE428693T1 (de)
AU (2) AU2004299316B2 (de)
CA (2) CA2854783C (de)
CZ (1) CZ305964B6 (de)
DE (1) DE602004020667D1 (de)
DK (1) DK1694641T3 (de)
ES (1) ES2325266T3 (de)
GB (1) GB0329379D0 (de)
IL (2) IL175940A (de)
WO (1) WO2005058812A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008037782A (ja) * 2006-08-04 2008-02-21 Daiichi Fine Chemical Co Ltd プロスタグランジン誘導体の製造方法
US7642370B2 (en) 2006-08-07 2010-01-05 Daiichi Fine Chemical Co., Ltd. Method for preparing prostaglandin derivative
AR071312A1 (es) * 2008-04-09 2010-06-09 Scinopharm Taiwan Ltd Proceso para la preparacion de analogos de prostaglandina y sus intermediarios
EP2135860A1 (de) * 2008-06-20 2009-12-23 Sandoz AG Verbesserter Herstellungsverfahren für Bimatoprost
EP2454227B1 (de) 2009-07-13 2020-08-19 Patheon API Services Inc. Prostanoid-synthese
US8664275B2 (en) 2009-11-02 2014-03-04 Shanghai Techwell Biopharmaceutical Co., Ltd. Crystalline form of Bimatoprost, preparation method and use thereof
JP6212485B2 (ja) * 2011-06-02 2017-10-11 キノイン・ゼー・エル・テー プロスタグランジンアミドの新規製造方法
HU231203B1 (hu) * 2011-12-21 2021-10-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Új eljárás travoprost előállítására
EP2822927A1 (de) * 2012-03-09 2015-01-14 Instytut Farmaceutyczny Verfahren zur herstellung von prostaglandin-f2-alpha-analogen
CN104884006B (zh) 2012-10-26 2017-12-15 弗赛特影像5股份有限公司 用于持续释放药物到眼睛的眼科系统
KR102311896B1 (ko) 2013-09-30 2021-10-14 패턴 에이피아이 서비시즈 인코포레이티드 복분해를 사용하는 프로스타글란딘 및 프로스타글란딘 중간체의 합성 경로
US20160296532A1 (en) 2015-04-13 2016-10-13 Forsight Vision5, Inc. Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
EP3235810A1 (de) 2016-04-19 2017-10-25 Gentec, S.A. Verfahren zur herstellung von bimatoprost

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1582853A (en) * 1977-06-16 1981-01-14 Ici Ltd Prostane derivatives
JPS562979A (en) * 1979-06-19 1981-01-13 Ono Pharmaceut Co Ltd Prostaglandin i2 analog compound, its preparation, and pharmaceutical composition containing the same
JPS57171965A (en) * 1981-04-15 1982-10-22 Teijin Ltd Novel prostaglandin intermediate and its preparation
US4708966A (en) * 1986-06-27 1987-11-24 The Procter & Gamble Company Novel anti-inflammatory agents, pharmaceutical compositions and methods for reducing inflammation
JPS63188687A (ja) * 1987-01-30 1988-08-04 Sagami Chem Res Center 有機ケイ素化合物の製造方法
JP2536026B2 (ja) * 1988-03-10 1996-09-18 史衛 佐藤 α,β―置換シクロペンタノン誘導体の製造法
US5698733A (en) * 1994-09-30 1997-12-16 Alcon Laboratories, Inc. Use of 9-deoxy prostaglandin derivatives to treat glaucoma
US6015922A (en) * 1997-12-19 2000-01-18 Alcon Laboratories, Inc. N-alkyl-N-alkoxycarboxamides and methods of use in prostaglandin synthesis
GB9908327D0 (en) * 1999-04-12 1999-06-09 Chirotech Technology Ltd Process for the preparation of prostaglandin precursors
CA2384148A1 (en) * 1999-09-06 2001-03-15 Taisho Pharmaceutical Co., Ltd. Prostaglandin e analogues
US20030187071A1 (en) * 2001-07-17 2003-10-02 Henegar Kevin E. Process and intermediates to prepare latanoprost
RU2267480C2 (ru) * 2001-07-17 2006-01-10 Фармация Энд Апджон Компани Способ и промежуточные соединения для получения латанопроста

Also Published As

Publication number Publication date
WO2005058812A2 (en) 2005-06-30
CZ305964B6 (cs) 2016-05-25
JP5653827B2 (ja) 2015-01-14
IL217670A (en) 2013-02-28
JP2013231053A (ja) 2013-11-14
AU2004299316A1 (en) 2005-06-30
JP2011201883A (ja) 2011-10-13
GB0329379D0 (en) 2004-01-21
IL175940A (en) 2012-05-31
JP5795354B2 (ja) 2015-10-14
EP1694641B1 (de) 2009-04-15
KR20060118555A (ko) 2006-11-23
WO2005058812A3 (en) 2005-10-13
DE602004020667D1 (en) 2009-05-28
CA2854783C (en) 2017-01-10
CA2854783A1 (en) 2005-06-30
EP1694641A2 (de) 2006-08-30
JP2007517780A (ja) 2007-07-05
CN101486699B (zh) 2012-06-27
CA2549056C (en) 2014-09-02
CZ2006386A3 (cs) 2006-11-15
ES2325266T3 (es) 2009-08-31
DK1694641T3 (da) 2009-07-20
AU2011200763B2 (en) 2013-05-30
AU2011200763A1 (en) 2011-03-17
CN101486699A (zh) 2009-07-22
JP4764828B2 (ja) 2011-09-07
AU2004299316B2 (en) 2011-01-06
CN1894209B (zh) 2010-12-22
CA2549056A1 (en) 2005-06-30
CN1894209A (zh) 2007-01-10
IL175940A0 (en) 2006-10-05

Similar Documents

Publication Publication Date Title
IL175940A0 (en) Prostaglandin synthesis
UA98326C2 (ru) Способ получения амидного соединения, промежуточные соединения, амидное соединение, его применение, пестицидная композиция и способ борьбы с вредными членистоногими
RS51136B (sr) Supstituisani pirolopiridini, kompozicije koje ih sadrže, postupak za njihovo dobijanje i upotreba
DK1451155T3 (da) Sammensætninger, metoder og kits i forbindelse med luminescerende forbindelser
HUP0402507A2 (hu) N(fenilszulfonil)glicin-származékok, alkalmazásuk és az ezeket tartalmazó gyógyászati készítmények
FI971312A0 (fi) Uudet prostaglandiinisyntaasin estäjät
IN2014CN00532A (de)
TW200635585A (en) Monocyclic substituted methanones
EA200870321A1 (ru) Способ получения 4-оксохинолинового соединения
SE9904850D0 (sv) Novel process and intermediates
EA200300927A1 (ru) Новый способ промышленного синтеза тетрасложных эфиров 5-[бис(карбоксиметил)амино]-3-карбоксиметил-4-циано-2-тиофенкарбоновой кислоты и применение для синтеза бивалентных солей ранелиновой кислоты и их гидратов
ATE402185T1 (de) Verfahren für fluorcytidinderivate
DE69529619T2 (de) Pyrimidinylpyrazolderivate
HUP0401600A2 (hu) Eljárás 14-hidroximorfin-származékok előállítására
EA200700767A1 (ru) Способ получения пиразолов
HUP0201357A2 (hu) Aszimmetrikus rézkomplex, előállítása, és eljárás ciklopropánkarbonsav-észter-származékok előállítására felhasználásával
DE60235365D1 (de) Verfahren zur herstellung von 7-amino-syn-3,5-dihydroxyheptansäurederivaten und zwischenverbindungen diesesverfahrens und deren herestellung
BRPI0416678A (pt) pirazolpirimidinas
DK0873327T3 (da) Fremgangsmåde til fremstilling af 2-chlor-5-chlormethyl-thiazol
EP1378502A4 (de) Kettenförmiger oligomilchsäureester
NO20053712L (no) Fremgangsmate for fremstilling av substituerte imidazolderivater og mellomprodukter anvendt i fremgangsmaten
EA200401077A1 (ru) 2-оксазоламины и их применение в качестве антагонистов рецептора 5-ht2b
DK1347960T3 (da) Fremgangsmåde til fremstilling af (+/-) trans-4-p-fluorphenyl-3-hydromethyl-1-methylpiperidin
MY151167A (en) Benzimidazole compound
HUP0303686A2 (hu) Eljárás Delta1-pirrolin-származékok előállítására és az új intermedierek

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1694641

Country of ref document: EP